Sign up to save your podcastsEmail addressPasswordRegisterOrContinue with GoogleAlready have an account? Log in here.
The CEimpact Podcast features two shows: GameChangers Clinical Updates Precept2PracticeGameChangers Clinical Update Series: The GameCha... more
FAQs about CEimpact Podcast:How many episodes does CEimpact Podcast have?The podcast currently has 391 episodes available.
July 31, 2020Rational Use of Skeletal Muscle Relaxants | GameChangersGeoff Wall, PharmD delivers another great podcast. Pharmacists see skeletal muscle relaxant prescriptions daily but how much real experience do we have with these drugs? Do they work? Are they safe? This episode covers what should every pharmacist know about these medications.This episode is accredited for CPE. For CE details and to claim credit, click here: https://bit.ly/2CEy161 See omnystudio.com/listener for privacy information.Follow CEimpact on Social Media:LinkedInInstagram...more27minPlay
July 24, 2020Dexamethasone for Severe COVID Pneumonia: What Does the Data Show?Overinflamation or cytokine storm is said to be the driver of acute respiratory disorder disease (ARDS) in COVID patients. A recent study conducted in the United Kingdom suggests that the steroid dexamethasone may be a weapon for prevention. In this episode, we discuss the study that caused the National Health Service in the U.K. and the CDC to change their recommendations for steroids and severe COVID.Additional Resources/ReferencesRamdomised Evaluation of COVID-19 Therapy: https://www.recoverytrial.net/ This episode is accredited for CPE. For CE details and to claim credit, click here: https://bit.ly/3h8OfTR See omnystudio.com/listener for privacy information.Follow CEimpact on Social Media:LinkedInInstagram...more27minPlay
July 17, 2020COVID Infections and the Latinx Patient: Perspectives from the Front Lines | GameChangersThe COVID-19 pandemic has disproportionally affected Latinx Americans. Learn how pharmacists can optimize patient care for Latinx patients by discussing how to overcome economic and language barriers. In this episode, we'll talk with Dr. Sally Haack who cares for Latinx patients on a daily basis in her pharmacy practice.Special guest: Sally Haack, PharmD, BCPS Associate Professor Drake UniversityThis episode is accredited for CPE. For CE details and to claim credit click here: https://bit.ly/2YogiIp See omnystudio.com/listener for privacy information.Follow CEimpact on Social Media:LinkedInInstagram...more27minPlay
July 10, 2020Cognitive Effects of Anticholinergics | GameChangersMany patients over age 65 take daily medications that have anticholinergic properties. We know the addition of these drugs can affect quality of life and cognition. In this episode, we talk with Dr. Kristin Meyer, an expert in geriatrics to explore the latest data and discuss what Pharmacists can do to promote the appropriate use of anticholinergics.Additional Resources/ReferencesBeers Criteria:By the 2019 American Geriatrics Society Beers Criteria® Update Expert Panel. American Geriatrics Society 2019 Updated AGS Beers Criteria® for Potentially Inappropriate Medication Use in Older Adults. J Am Geriatr Soc. 2019;67(4):674-694. doi:10.1111/jgs.15767Anticholinergic Risk Scale:Rudolph JL, Salow MJ, Angelini MC, McGlinchey RE. The Anticholinergic Risk Scale and Anticholinergic Adverse Effects in Older Persons. Arch Intern Med. 2008;168(5):508–513. doi:10.1001/archinternmed.2007.106Recent arge study associating anticholinergics with dementia:Coupland CAC, Hill T, Dening T, Morriss R, Moore M, Hippisley-Cox J. Anticholinergic Drug Exposure and the Risk of Dementia: A Nested Case-Control Study. JAMA Intern Med. 2019;179(8):1084–1093. doi:10.1001/jamainternmed.2019.0677This episode is accredited for CPE. See omnystudio.com/listener for privacy information.Follow CEimpact on Social Media:LinkedInInstagram...more24minPlay
July 03, 2020New 2020 ACR Guidelines for the Treatment of Gout | GameChangersThe American College of Rheumatology recently published new guidelines for the treatment of Gout. While gout is well understood and the medications to treat gout are both effective and affordable, implementation of the new ARC guidelines will, ideally, lead to improved quality of care for patients with gout. In this episode, Dr. Wall discusses guideline changes and important pearls so pharmacists may optimize medication therapy for patients suffering from gout.This episode is accredited for CPE. For CE details and to claim credit click here: https://bit.ly/2YchMVZ See omnystudio.com/listener for privacy information.Follow CEimpact on Social Media:LinkedInInstagram...more23minPlay
June 26, 2020Racism is a Public Health Emergency | GameChangersRacism is a public health emergency and a root cause of social determinants of health. If we are to practice patient-centered care, and education our pharmacists to better serve their patients, we ought to act to dismantle structural racism and start by having some honest conversations. In this episode, we'll talk with Dr. Vibhuti Arya about our role as pharmacists in addressing this public health emergency.Special Guest: Vibhuti Arya, PharmDAssociate Clinical Professor, St. John's UniversityClinical Advisor, New York City Department of Health and Mental HygieneView Dr. Arya's Tedx Talk here: https://www.youtube.com/watch?v=vnYE0n7Tx_o This episode is accredited for CPE. For CE details and to claim credit click here: https://bit.ly/2BgRwRs Racism, SDOH, social determinants of health, anti-racist See omnystudio.com/listener for privacy information.Follow CEimpact on Social Media:LinkedInInstagram...more31minPlay
June 19, 2020Vitamin D: Repletion doses and the evidence of potential toxicity | GameChangersRecently news suggests low vitamin D levels have been associated with increased risk of COVID-related morbidity and mortality. We know that vitamin D is a safe fat soluable vitamin that is difficult to "overdose" on. What should the pharmacist know in terms of repletion dose and signs of toxicity? Since many patients do not get enough vitamin D in their diets, large medical societies and organizations recommend daily vitamin D for this reason. This episode will focus not on the claims of efficacy of Vitamin D in COVID, but will instead discuss how your patients can replete vitamin D levels and the risks of toxicity in overrepletion.This episode is accredited for CPE. For CE details and to claim credit click here: https://bit.ly/2N87PCD See omnystudio.com/listener for privacy information.Follow CEimpact on Social Media:LinkedInInstagram...more25minPlay
June 12, 2020Remdesivir for COVID-19: The NIAID Study Behind its Approval | GameChangersRecently, Remdesivir was given Emergency Use Authorization (EUA) status by the U.S. Food and Drug Administration (FDA) for use in COVID based on a heretofore unpublished study. The study, conducted by NIAID, is the subject of this episode.This episode is accredited for CPE. For CE details and to claim credit click here: https://bit.ly/3hn191p See omnystudio.com/listener for privacy information.Follow CEimpact on Social Media:LinkedInInstagram...more23minPlay
June 05, 2020Treating the other Epidemic: Buprenorphine for Opioid Use Disorder | GameChangersBuprenorphine has been shown in numerous studies to be safe and effective in opioid use disorder, yet < 10% patients with Opioid Use Disorder receive drug treatment. In this episode, we discuss what the general pharmacist needs to know about the most powerful weapon we have for Opioid Use Disorder: buprenorphineThis episode is accredited for CPE. This episode is accredited for CPE. For CE details and to claim credit click here: https://bit.ly/3dPEj0i See omnystudio.com/listener for privacy information.Follow CEimpact on Social Media:LinkedInInstagram...more22minPlay
May 29, 2020Evidence for SGLT2 Drugs for Heart Failure in Patients without Diabetes | GameChangersGeoff Wall, PharmD & Jamie Pitlick, PharmD discussing SGLT2 inhibitors, also called gliflozins, are a class of medications that inhibit reabsorption of glucose in the kidney and therefore lower blood sugar. Recently SGLTs, which are currently indicated for Type 2 diabetes, have been investigated and received FDA approval for Heart failure with reduced ejection fraction (HFrEF). Listen in to this episode to discover more about how these drugs work in this (HFrEF) disease state.This episode is accredited for CPE. This episode is accredited for CPE. For CE details and to claim credit click here: https://bit.ly/2ApMvWw See omnystudio.com/listener for privacy information.Follow CEimpact on Social Media:LinkedInInstagram...more26minPlay
FAQs about CEimpact Podcast:How many episodes does CEimpact Podcast have?The podcast currently has 391 episodes available.